Recruiting Epilepsy Studies in Chesterfield
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)...
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures...
About Epilepsy Clinical Trials in Chesterfield
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects about 50 million people worldwide. Treatment includes antiseizure medications, surgery, and neurostimulation devices.
There are currently 2 epilepsy clinical trials recruiting participants in Chesterfield, MISSOURI. These studies are seeking a combined 280 participants. Research is being sponsored by Praxis Precision Medicines. Clinical trial participation is free and participants receive study-related medical care at no cost.
Epilepsy Clinical Trials in Chesterfield — FAQ
Are there epilepsy clinical trials in Chesterfield?
Yes, there are 2 epilepsy clinical trials currently recruiting in Chesterfield, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chesterfield?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chesterfield research site will contact you about next steps.
Are clinical trials in Chesterfield free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chesterfield studies also compensate for your time and travel.
What epilepsy treatments are being tested?
The 2 active trials in Chesterfield are testing new therapies including novel drugs, biologics, and treatment approaches for epilepsy.
Data updated March 2, 2026 from ClinicalTrials.gov